Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment;Modificación del perfil clínico de los ictus en enfermos con fibrilación auricular. Efecto del tratamiento antitrombótico

Revista de Neurologia

Volumn 38, Issue 5, 2004, Pages 401-405

  Garcia Escriva A ^a   Lopez Hernandez N ^a   Hernandez Lorido R ^a   Oliver Navarrete, C ^a   Bustos, S ^a   Carneado Ruiz, J ^a   Gracia Fleta, F ^a   Moltó Jordá, José Manuel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Anticoagulants; Antiplatelets; Atrial fibrillation; Prognosis; Prophylaxis; Stroke

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BRAIN EMBOLISM; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; STROKE; TRANSIENT ISCHEMIC ATTACK; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC BRAIN DISEASE; CLASSIFICATION; COHORT ANALYSIS; COMORBIDITY; DRUG SCREENING; HOSPITALIZATION; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; SPAIN;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; CEREBRAL INFARCTION; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; COMORBIDITY; DRUG EVALUATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL EMBOLISM; ISCHEMIC ATTACK, TRANSIENT; MALE; PLATELET AGGREGATION INHIBITORS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN;

EID: 2342422754     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Krahn AD, Manfreda J, Tate RM, Mathewson FA, Luddy TE. The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitova Follow-up Study. Am J Med 1995; 98: 476-84.
2. Wolf PA, Abbott RD, Kannet WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991; 22: 983-8.
3. Lévy S. Epidemiology and classification of atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9: 78-82.
4. Connolly SJ, Laupacis A, Gent M, Roberts RS, Cains JA, Joyner C. Canadian Atrial Fibrillation Anticoagulaton (CAFA) Study. J Am Coll Cardiol 1991; 18: 349-55.
5. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation -the Copenhagen AFASAK study. Lancet 1989; 1: 175-9.
6. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990; 323: 1505-11.
7. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991; 84: 527-39.
8. Stroke Prevention in Atrial Fibrillation Investigators. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 1994; 343: 687-91.
9. Ezekowitz MD, James KE, Nazarian SM, Daventport J, Broderick JP, Gupta SR, et al. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med 1992; 327:1406-12.
10. European Atrial Fibrillation Trial (EAFT) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993; 342: 1255-62.
11. Sra J, Dhala A, Blanck Z, Deshpande S, Cooley R, Akthar M. Atrial fibrillation: epidemiology, mechanisms and management. Curr Probl Cardiol 2000; 25: 405-524.
12. Moltó JM, Moreno A, Martínez-García F, Morales A, Fernández-Barreiro A. Patología hemorrágica intraparenquimatosa en pacientes mayores de 70 años: un estudio comparativo con sujetos jóvenes. Rev Neurol 1996; 24: 158-62.
13. Lahoz CH, Mateos V, Salas-Puig X, Tanon A, Guisasola LM. Pronóstico de las hemorragias intracerebrales supratentoriales. Neurología 1994; 9: 269-76.
14. Bramford JM, Sandercock P, Dennis M, Burn M, Warlow C. Classification and natural history of clinically identifiable subtypes of acute cerebral infarction. Lancet 1991; 337: 1521-6.
15. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial firillation in a population based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-4.
16. Karzui S, Levi CR, Jones EF, Quang L, Calafiore P, Donnan GA. Lacunar stroke: transoesophageal echocardiographic factors influencing long-term prognosis. Cerebrovasc Dis 2001; 12: 325-30.
17. Kottkamp H, Hindricks H, Breithardt G. Role of anticoagulation therapy in atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9: 86-96.